Please use this identifier to cite or link to this item: http://111.93.178.142:25000/jspui/handle/123456789/3733
Full metadata record
DC FieldValueLanguage
dc.contributor.authorZahra Shakerinia-
dc.date.accessioned2026-05-06T07:07:05Z-
dc.date.available2026-05-06T07:07:05Z-
dc.date.issued2026-05-06-
dc.identifier.urihttp://111.93.178.142:25000/jspui/handle/123456789/3733-
dc.descriptionVol. 63, No. 9, p 755en_US
dc.language.isoenen_US
dc.subjectARF6 inhibitionen_US
dc.subjectDrug resistanceen_US
dc.subjectTyrosine kinase inhibitoren_US
dc.subjectApoptosisen_US
dc.subjectTumor microenvironmenten_US
dc.titleEvaluation of NAV2729 in combination with imatinib in apoptosis induction in chronic myeloid leukemia cells (K562), an in vitro studyen_US
dc.typeOtheren_US
Appears in Collections:Vol 63, No. 9, 2025

Files in This Item:
File Description SizeFormat 
1.pdfVol. 63, No. 9, p 755161.66 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.